Dan Feldheim at the University of Colorado has received a Grand Challenges Explorations Phase II grant to continue exploring how gold nanoparticles can be tailored to circumvent many viral and bacterial evolutionary drug resistance mechanisms. Learn more about his innovative idea for developing new drugs and improving current therapies and the next steps in his Explorations project.